Difficulty: Medium
Average Score: 92%
Practice
Regarding perinatal depression, which of the following statements is FALSE?
Correct answer
B
Rationale
In this question on possible complications in early pregnancy, the FALSE statement is option B) "Paroxetine is a good choice for antenatal depression."
The correct answer is B because paroxetine is generally not recommended during pregnancy due to concerns about potential risks to the fetus. Paroxetine is classified as a Category D medication by the FDA, indicating potential risks to the fetus based on human data. It is associated with an increased risk of congenital malformations, particularly cardiac defects, when used during the first trimester.
Option A is true because perinatal depression can be diagnosed using the DSM-5 criteria. Option C is also true as perinatal depression can occur in women with no prior history of mental illness. Option D is false because clomipramine is not associated with more severe neonatal effects than other TCAs.
In an educational context, it is crucial for healthcare providers to be aware of the risks and benefits of medications used during pregnancy to make informed decisions that prioritize the health and safety of both the mother and the developing fetus. Understanding the implications of different treatment options for perinatal depression is essential in providing comprehensive care for pregnant individuals.
The correct answer is B because paroxetine is generally not recommended during pregnancy due to concerns about potential risks to the fetus. Paroxetine is classified as a Category D medication by the FDA, indicating potential risks to the fetus based on human data. It is associated with an increased risk of congenital malformations, particularly cardiac defects, when used during the first trimester.
Option A is true because perinatal depression can be diagnosed using the DSM-5 criteria. Option C is also true as perinatal depression can occur in women with no prior history of mental illness. Option D is false because clomipramine is not associated with more severe neonatal effects than other TCAs.
In an educational context, it is crucial for healthcare providers to be aware of the risks and benefits of medications used during pregnancy to make informed decisions that prioritize the health and safety of both the mother and the developing fetus. Understanding the implications of different treatment options for perinatal depression is essential in providing comprehensive care for pregnant individuals.